| 1. |
Frydendal T, Christensen R, Mechlenburg I, et al. Total hip replacement or resistance training for severe hip osteoarthritis. N Engl J Med, 2024, 391(17): 1610-1620.
|
| 2. |
Anil U, Terner B, Karim MA, et al. Total hip arthroplasty in challenging settings: Acetabular fractures, adolescents, conversions, and developmental dysplasia of the hip. J Arthroplasty, 2025, 40(9S1): S49-S58.
|
| 3. |
陳創奇. 加速康復外科理念中的微創手術. 中華胃腸外科雜志, 2022, 25(7): 632-635.
|
| 4. |
Wang X, Dai J, Wu Z, et al. Direct anterior approach total hip arthroplasty for femoral neck fractures in the lateral position. Clin Interv Aging, 2024, 19: 883-889.
|
| 5. |
Jin X, Chen G, Chen M, et al. Comparison of postoperative outcomes between bikini-incision via direct anterior approach and posterolateral approach in simultaneous bilateral total hip arthroplasty: a randomized controlled trial. Sci Rep, 2023, 13(1): 7023. doi: 10.1038/s41598-023-29146-2.
|
| 6. |
翟冬超, 代志鵬, 高宗炎. 直接前方入路與后外側入路全髖關節置換術治療股骨頭壞死的臨床療效分析. 實用中西醫結合臨床, 2023, 23(10): 106-108, 112.
|
| 7. |
張曉璐, 何英, 吳茂潔, 等. 全髖關節置換術后功能康復軌跡的范圍綜述. 護士進修雜志, 2025, 40(18): 1973-1978.
|
| 8. |
Reinhard J, Schindler M, Leiss F, et al. No clinically significant difference in postoperative pain and side effects comparing conventional and enhanced recovery total hip arthroplasty with early mobilization. Arch Orthop Trauma Surg, 2023, 143(10): 6069-6076.
|
| 9. |
Kostyun RO, Witmer DK, Lucchio P, et al. The PROMIS-10 global mental health T-score: An independent predictor of in-hospital recovery following a total hip arthroplasty. J Am Acad Orthop Surg, 2025, 33(21): 1200-1207.
|
| 10. |
Paredes AC, Costa P, Almeida A, et al. Presurgical anxiety and acute postsurgical pain predict worse chronic pain profiles after total knee/hip arthroplasty. Arch Orthop Trauma Surg, 2025, 145(1): 118. doi: 10.1007/s00402-024-05681-z.
|
| 11. |
鄭田麗, 王興華, 岳孟婷. 疼痛災難化、跌倒效能對全髖關節置換術患者術后早期運動恐懼的影響. 國際護理學雜志, 2025, 44(16): 2944-2949.
|
| 12. |
Verdaguer-Figuerola A, Andriola V, Soler-Cano A, et al. Local infiltration anesthesia in total hip arthroplasty: A randomized controlled trial. Arthroplast Today, 2025, 33: 101692. doi: 10.1016/j.artd.2025.101692.
|
| 13. |
Kuchálik J, Magnuson A, Lundin A, et al. Local infiltration analgesia or femoral nerve block for postoperative pain management in patients undergoing total hip arthroplasty. A randomized, double-blind study. Scand J Pain, 2017, 16: 223-230.
|
| 14. |
Rantakokko M, Ter?s M, Tarkkila P, et al. Anesthesia and analgesia methods in primary total hip arthroplasty and primary total knee arthroplasty-a survey of nordic anesthesiologists. Acta Anaesthesiol Scand, 2025, 69(7): e70091. doi: 10.1111/aas.70091.
|
| 15. |
El-Boghdadly K, Short AJ, Gandhi R, et al. Addition of dexamethasone to local infiltration analgesia in elective total hip arthroplasty: a double-blind, randomized control trial. Reg Anesth Pain Med, 2019, 27: rapm-2019m-100873m. doi: 10.1136/rapm-2019-100873.
|
| 16. |
Orebaugh SL, Ligocki M, Guo H, et al. Liposomal bupivacaine: examining the factors behind inconsistent analgesic results. Reg Anesth Pain Med, 2025, 17: rapm-2024m-106189m. doi: 10.1136/rapm-2024-106189.
|
| 17. |
Huang H, Wei S, Lan Y, et al. Liposomal bupivacaine versus ropivacaine perianal infiltration for postoperative analgesia of haemorrhoidectomy: a multicentre, randomised controlled trial. BMJ Open, 2025, 15(10): e098484. doi: 10.1136/bmjopen-2024-098484.
|
| 18. |
Osuchukwu O, Gagnon J, Richard J, et al. Liposomal bupivacaine in transversus abdominis plane blocks for lower abdominal surgery. Pain Pract, 2024, 24(5): 717-723.
|
| 19. |
徐鑫, 汪小海, 湯春艷, 等. 布比卡因脂質體注射液研究進展. 醫藥導報, 2024, 43(1): 91-96.
|
| 20. |
Jiang H, Ma Q, Dong J, et al. The effect of liposomal bupivacaine for surgical wound infiltration: A meta-analysis of randomised controlled trials. Int Wound J, 2023, 20(5): 1591-1608.
|
| 21. |
Zhiyuan C, Jiahao S, Bowen M, et al. Total hip arthroplasty with tantalum rod extraction via direct anterior approach based on preoperative DCE-MRI and AI: a case report. Ann Med Surg (Lond), 2025, 87(6): 3894-3901.
|
| 22. |
彭浩彬, 溫嘉筠, 吳先平, 等. 布比卡因脂質體的臨床應用與爭議性. 中國醫藥指南, 2024, 22(21): 54-57.
|
| 23. |
Thijssen M, Timmerman L, Koning NJ, et al. Multimodal analgesia practices for knee and hip arthroplasties in the Netherlands. A prospective observational study from the PAIN OUT registry. PLoS One, 2022, 17(12): e0279606. doi: 10.1371/journal.pone.0279606.
|
| 24. |
沈彬, 翁習生, 廖刃, 等. 中國髖、膝關節置換術加速康復—圍術期疼痛與睡眠管理專家共識. 中華骨與關節外科雜志, 2016, 9(2): 91-97.
|
| 25. |
周宗科, 翁習生, 曲鐵兵, 等. 中國髖、膝關節置換術加速康復—圍術期管理策略專家共識. 中華骨與關節外科雜志, 2016, 9(1): 1-9.
|
| 26. |
Curtis GB, Johnson GH, Clark P, et al. Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol, 1999, 55(6): 425-429.
|
| 27. |
Takahashi M, Ohara T, Yamanaka H, et al. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment. Palliat Med, 2003, 17(8): 673-678.
|
| 28. |
李駿然, 翟婧秀, 趙洪波, 等. 牽引床輔助直接前側入路全髖關節置換治療老年股骨頸骨折. 中國組織工程研究, 2023, 27(27): 4312-4317.
|
| 29. |
可雨奇, 陳長健, 吳浩, 等. 改良直接前方入路與直接前方入路初次全髖關節置換者12個月隨訪結果比較. 中國組織工程研究, 2023, 27(9): 1377-1382.
|
| 30. |
Chen J, Loke RWK, Wong EY, et al. Efficacy of pericapsular nerve group block (PENG) compared to local infiltration analgesia (LIA) after total hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Musculoskelet Surg, 2026, 110(1): 29-39.
|
| 31. |
Rong L, Qin T, Yu S, et al. Effects of pericapsular nerve group block versus local anesthetic infiltration for postoperative analgesia in total hip arthroplasty: A protocol for systematic review and meta-analysis. PLoS One, 2025, 20(3): e0319102. doi: 10.1371/journal.pone.0319102.
|
| 32. |
Wang HY, Xiao Q, Luo ZY, et al. A new cocktail formula with diprospan of local infiltration analgesia in primary total hip arthroplasty: A prospective, randomized, controlled, observer-blinded study. Orthop Surg, 2022, 14(8): 1799-1807.
|
| 33. |
Vereen MS, Bidault VJ, Krabbendam E, et al. The effectiveness of liposomal bupivacaine in ultrasound-guided abdominal wall blocks after open abdominal surgery: A systematic review. Pain Pract, 2025, 25(3): e70016. doi: 10.1111/papr.70016.
|
| 34. |
Cheng H, Ding L, Zhang K, et al. Multilevel retro-superior costotransverse ligament block with liposomal bupivacaine for open hepatectomy: a case report. J Med Case Rep, 2025, 19(1): 633. doi: 10.1186/s13256-025-05620-5.
|
| 35. |
Virk M, Cecora A, Papalia AG, et al. Comparison of opioid-sparing effect of liposomal vs nonliposomal bupivacaine for interscalene block in total shoulder arthroplasty: a randomized controlled trial. JSES Int, 2024, 9(3): 741-747.
|
| 36. |
Lin JH, Huo T, Pandya S, et al. Real-world impact of treatment with liposomal bupivacaine on health care resource utilization, opioid consumption, and cost among patients undergoing total knee arthroplasty in ambulatory surgical settings in the united states. J Arthroplasty, 2025, 17: S0883-5403. doi: 10.1016/j.arth.2025.10.018.
|
| 37. |
Ye X, Shang K, Zhao L, et al. Liposomal bupivacaine versus conventional anesthetics in adductor canal block for total knee arthroplasty: a meta-analysis of randomized controlled trials. BMC Anesthesiol, 2025, 25(1): 401. doi: 10.1186/s12871-025-03289-3.
|
| 38. |
Zhang L, Yang S, Liu X, et al. Impact of liposomal bupivacaine on subjective recovery quality after surgery: a meta-analysis of randomized controlled trials. Front Med (Lausanne), 2025, 12: 1655756. doi: 10.3389/fmed.2025.1655756.
|
| 39. |
Bowen J, Rainey JP, Linthicum J, et al. Liposomal bupivacaine versus standard periarticular injections in total hip and knee arthroplasty: a prospective, randomized non-inferiority trial. SICOT J, 2025, 11: 17. doi: 10.1051/sicotj/2025012.
|
| 40. |
Ma TT, Wang YH, Jiang YF, et al. Liposomal bupivacaine versus traditional bupivacaine for pain control after total hip arthroplasty: A meta-analysis. Medicine (Baltimore), 2017, 96(25): e7190. doi: 10.1097/MD.0000000000007190.
|
| 41. |
Boyev A, Popat K, Gottumukkala VNR, et al. Postoperative pain scores and opioid use after standard bupivacaine vs liposomal bupivacaine regional blocks for abdominal cancer surgery: A propensity score matched study. Am J Surg, 2024, 237: 115770. doi: 10.1016/j.amjsurg.2024.05.011.
|
| 42. |
Beachler JA, Kopolovich DM, Tubb CC, et al. Liposomal bupivacaine in total hip arthroplasty: Do the results justify the cost? J Orthop, 2017, 14(1): 161-165.
|
| 43. |
Zheng S, Zhu J, Chen Z, et al. AI-assisted direct anterior approach versus posterolateral approach in total hip arthroplasty: a retrospective cohort study based on artifact-reduced CT 3D reconstruction. Front Bioeng Biotechnol, 2025, 13: 1509200. doi: 10.3389/fbioe.2025.1509200.
|
| 44. |
Yu M, Yuan W, Xia Z, et al. Characterization of exparel bupivacaine multivesicular liposomes. Int J Pharm, 2023, 639: 122952. doi: 10.1016/j.ijpharm.2023.122952.
|
| 45. |
Ueki S, Shoji T, Kaneta H, et al. Preoperative risk factors for persistent pain after total hip arthroplasty for hip osteoarthritis: The influence of neuropathic pain, central sensitization, and pain catastrophizing. Cureus, 2025, 17(3): e80698. doi: 10.7759/cureus.80698.
|
| 46. |
Perets I, Walsh JP, Mu BH, et al. Intraoperative infiltration of liposomal bupivacaine vs bupivacaine hydrochloride for pain management in primary total hip arthroplasty: A prospective randomized trial. J Arthroplasty, 2018, 33(2): 441-446.
|
| 47. |
Danoff JR, Goel R, Sutton R, et al. How much pain is significant? Defining the minimal clinically important difference for the visual analog scale for pain after total joint arthroplasty. J Arthroplasty, 2018, 33(7S): S71-S75.
|
| 48. |
Vij N, Supra R, Vanvalkenburg D, et al. The role for high volume local infiltration analgesia with liposomal bupivacaine in total hip arthroplasty: A scoping review. Orthop Rev (Pavia), 2022, 14(3): 37101. doi: 10.52965/001c.37101.
|
| 49. |
Gould J, Sandor A, Lin JH, et al. Liposomal bupivacaine for sleeve gastrectomy is associated with improved opioid outcomes and lower odds of opioid use disorder: claims-based analysis. Surg Obes Relat Dis, 2025, 21(4): 449-456.
|
| 50. |
Daher M, Singh M, Nassar JE, et al. Liposomal bupivacaine reduces postoperative pain and opioids consumption in spine surgery: a meta-analysis of 1, 269 patients. Spine J, 2025, 25(3): 411-418.
|